→Appendix 1: antihistamines, non-
sedating
PDF page 316
▶Uncommon Agitation. asthenia. diarrhoea. malaise.
paraesthesia. skin reactions
▶Rare or very rare Aggression. angioedema. confusion.
depression. hallucination. hepatic function abnormal.
insomnia. movement disorders. oculogyration. oedema.
seizure. syncope. tachycardia. taste altered.
thrombocytopenia. tic. tremor. urinary disorders. vision
disorders. weight increased
▶Frequency not known Abdominal pain. appetite increased.
dizziness. drowsiness. dry mouth. headache. memory
loss. nausea. pharyngitis. suicidal ideation. vertigo
SIDE-EFFECTS, FURTHER INFORMATION Non-sedating
antihistamines such as certirizine hydrochloride cause less
sedation and psychomotor impairment than the older
antihistamines, but can still occur; sedation is generally
minimal. This is because non-sedating antihistamines
penetrate the blood brain barrier to a much lesser extent.
PDF page 316
Most manufacturers of antihistamines advise
avoiding their use during pregnancy; however, there is no
evidence of teratogenicity.
PDF page 316
Most antihistamines are present in
breast milk in varying amounts; although not known to be
harmful, most manufacturers advise avoiding their use in
mothers who are breast-feeding.
PDF page 316
▶In adults Avoid if eGFR less than 10 mL/minute/1.73 m2.
▶In children Avoid if estimated glomerular filtration rate less
than 10 mL/minute/1.73 m2.
Dose adjustments ▶In adults Use half normal dose if eGFR
30–50 mL/minute/1.73 m2. Use half normal dose and
reduce dose frequency to alternate days if eGFR
10–30 mL/minute/1.73 m2.
▶In children Use half normal dose if estimated glomerular
filtration rate 30–50 mL/minute/1.73 m2. Use half normal
dose and reduce dose frequency to alternate days if
estimated glomerular filtration rate
10–30 mL/minute/1.73 m2.
PDF page 316